The TECOS trial demonstrated cardiovascular safety (non-inferiority to placebo) for sitagliptin, but it did not show a statistically significant reduction in MACE
We observed no significant changes in the percentage of insulin cells relative to proliferating cells between groups (Figure 1V)
Estas inyecciones replican la hormona pptido similar al glucagn tipo 1 (GLP-1)
But even today, more than three decades after BPC-157 was first synthesized, a grand total of three human studies have been conducted, and none of them were the kind of large-scale human trial thats typically part of the traditional drug-approval process
SGLT2 inhibitors can cause genitourinary infections, diabetic ketoacidosis (DKA), and volume depletion
Whether you're battling burnout, recovering from a bender, training hard, or just want to feel sharper NAD+ injections might be your new secret weapon